TFS Articles
Search by keyword, or choose a Focus Topic to view all articles within that area of study.
Found 191 Results
Page 3 of 22
Article
Data-Driven Decision-Making in Clinical Trials
Learn how real-time insights, analytics, and predictive modeling enhance efficiency, reduce risk, and accelerate time to market.
Read Now
Article
Driving Sustainability at TFS: 2025 Goals & Initiatives for Zero Waste Day
Learn how TFS is advancing sustainability in clinical research with innovative waste reduction initiatives in support of Zero Waste Day 2025!
Read Now
Article
Advancing Dermatology Drug Development: Key Takeaways from AAD 2025
Discover key takeaways from AAD 2025 and how emerging dermatology innovations are shaping clinical trials.
Read Now
Article
The Role of Technology in Transforming Dermatology Clinical Trials
Explore how advancements in AI, teledermatology, and wearable sensors are revolutionizing dermatology clinical trials, enhancing efficiency, patient access, and data accuracy.
Read Now
Article
TFS Advances Neuroscience Research with Data-Driven Innovations and AI
Discover how TFS HealthScience is revolutionizing neuroscience trials with AI, data-driven insights, and decentralized trials.
Read Now
Article
Rare Disease Day 2025: How Precision Medicine is Transforming Treatment for Rare Diseases
Explore how precision medicine is revolutionizing rare disease treatment through targeted therapies, gene editing, and AI-driven solutions.
Read Now
Article
The Future of Good Clinical Practice: Key Insights from the ICH E6(R3) Update
Explore the future of Good Clinical Practice with transformative updates in ICH E6(R3) guidelines in modern clinical research practices.
Read Now
Article
Revolutionizing Oncology Trials: The Power of Immunotherapy and Precision Medicine in Cancer Research
A comprehensive guide exploring the challenges and best practices in cancer immunotherapy clinical trials.
Read Now
Article
Next-Generation Oncology Research: How CROs Are Accelerating Oncology Drug Development
See how next-gen CROs leverage AI, digital biomarkers, & trial designs to accelerate oncology drug development & regulatory approval.
Read Now